Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
REATA PHARMACEUTICALS INC (RETA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 09/28/2023 |
SC 13D/A
| BIOGEN INC. reports a 0% stake in REATA PHARMACEUTICALS, INC. |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2023 |
4
| McGaughy R Kent Jr (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 25,004 shares
@ $0
Disposed/sold 2,896,901 shares
@ $0
Disposed/sold 4,591 shares
@ $0
Disposed/sold 280 shares
@ $0
Disposed/sold 1,692,857 options to buy
@ $0
Disposed/sold 51,095 options to buy
@ $0
Disposed/sold 3,109 options to buy
@ $0
Disposed/sold 278,309 options to buy
@ $0
Disposed/sold 6,300 options to buy
@ $130.92, valued at
$824.8k
Disposed/sold 699 options to buy
@ $130.92, valued at
$91.5k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
|
|
| 09/26/2023 |
8-K
| Quarterly results |
| 09/26/2023 |
SC 13D/A
| ROSE WILLIAM reports a 0% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 09/26/2023 |
4
| WORTLEY MICHAEL D (Chief Legal Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 49,701 shares
@ $0
Disposed/sold 16,500 options to buy
@ $121.29, valued at
$2M
Disposed/sold 70,000 options to buy
@ $27.32, valued at
$1.9M
Disposed/sold 63,650 options to buy
@ $36.71, valued at
$2.3M
Disposed/sold 62,800 options to buy
@ $22.57, valued at
$1.4M
Disposed/sold 60,400 options to buy
@ $24.75, valued at
$1.5M
Disposed/sold 34,500 options to buy
@ $55.73, valued at
$1.9M
Disposed/sold 17,250 options to buy
@ $55.73, valued at
$961.3k
Disposed/sold 24,000 options to buy
@ $207.2, valued at
$5M
|
|
| 09/26/2023 |
4
| Oliger Christy J. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 5,565 shares
@ $0
Disposed/sold 1,250 options to buy
@ $92.2, valued at
$115.3k
Disposed/sold 10,000 options to buy
@ $92.2, valued at
$922k
Disposed/sold 106 options to buy
@ $92.2, valued at
$9.8k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 180 options to buy
@ $146.01, valued at
$26.3k
Disposed/sold 5,620 options to buy
@ $34.76, valued at
$195.4k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 09/26/2023 |
4
| Loewen Andrea (SVP, Global Regulatory Affairs) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 28,416 shares
@ $0
Disposed/sold 11,250 options to buy
@ $196.23, valued at
$2.2M
Disposed/sold 9,000 options to buy
@ $121.29, valued at
$1.1M
Disposed/sold 35,000 options to buy
@ $27.32, valued at
$956.2k
Disposed/sold 47,738 options to buy
@ $36.71, valued at
$1.8M
|
|
| 09/26/2023 |
4
| Soni Manmeet Singh (COO, CFO and President) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 62,621 shares
@ $0
Disposed/sold 24,000 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 75,000 options to buy
@ $27.32, valued at
$2M
Disposed/sold 75,000 options to buy
@ $34.15, valued at
$2.6M
Disposed/sold 95,475 options to buy
@ $36.71, valued at
$3.5M
Disposed/sold 175,000 options to buy
@ $72.7, valued at
$12.7M
Disposed/sold 50,000 options to buy
@ $104.79, valued at
$5.2M
Disposed/sold 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 09/26/2023 |
4
| ROSE WILLIAM (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 379,281 shares
@ $0
Disposed/sold 11,618 shares
@ $0
Disposed/sold 19,795 shares
@ $0
Disposed/sold 7,886 shares
@ $0
Disposed/sold 20 shares
@ $0
Disposed/sold 45 shares
@ $0
Disposed/sold 29 shares
@ $0
Disposed/sold 180,909 shares
@ $0
Disposed/sold 129,308 options to buy
@ $0
Disposed/sold 1,732,998 options to buy
@ $0
Disposed/sold 87,776 options to buy
@ $0 |
|
| 09/26/2023 |
4
| Ruff Shamim (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 7,359 shares
@ $0
Disposed/sold 3,334 options to buy
@ $92.2, valued at
$307.4k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 780 options to buy
@ $146.01, valued at
$113.9k
Disposed/sold 443 options to buy
@ $34.76, valued at
$15.4k
Disposed/sold 1,405 options to buy
@ $34.76, valued at
$48.8k
Disposed/sold 576 options to buy
@ $93.61, valued at
$53.9k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 09/26/2023 |
4
| Meyer Colin John (Chief Innovation Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 81,633 shares
@ $0
Disposed/sold 74,304 options to buy
@ $0
Disposed/sold 24,000 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 30,000 options to buy
@ $27.32, valued at
$819.6k
Disposed/sold 70,000 options to buy
@ $27.32, valued at
$1.9M
Disposed/sold 95,475 options to buy
@ $36.71, valued at
$3.5M
Disposed/sold 90,000 options to buy
@ $22.57, valued at
$2M
Disposed/sold 87,700 options to buy
@ $24.75, valued at
$2.2M
Disposed/sold 35,500 options to buy
@ $55.73, valued at
$2M
Disposed/sold 17,750 options to buy
@ $55.73, valued at
$989.2k
Disposed/sold 25,000 options to buy
@ $207.2, valued at
$5.2M
|
|
| 09/26/2023 |
4
| Bir Dawn Carter (Chief Commercial Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 33,805 shares
@ $0
Disposed/sold 16,500 options to buy
@ $121.29, valued at
$2M
Disposed/sold 70,000 options to buy
@ $27.32, valued at
$1.9M
Disposed/sold 63,650 options to buy
@ $36.71, valued at
$2.3M
Disposed/sold 71,300 options to buy
@ $24.75, valued at
$1.8M
Disposed/sold 34,500 options to buy
@ $55.73, valued at
$1.9M
Disposed/sold 17,250 options to buy
@ $55.73, valued at
$961.3k
Disposed/sold 24,000 options to buy
@ $207.2, valued at
$5M
|
|
| 09/26/2023 |
4
| Patni Rajiv (EVP, Chief R&D Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 45,000 shares
@ $0
Disposed/sold 90,000 options to buy
@ $99.12, valued at
$8.9M
|
|
| 09/26/2023 |
4
| Ryder Steven (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,907 shares
@ $0
Disposed/sold 1,322 options to buy
@ $32.36, valued at
$42.8k
Disposed/sold 6,038 options to buy
@ $32.36, valued at
$195.4k
Disposed/sold 5,492 options to buy
@ $32.36, valued at
$177.7k
Disposed/sold 441 options to buy
@ $93.61, valued at
$41.3k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 09/26/2023 |
4
| Huff James Warren (CEO) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 122,480 shares
@ $0
Disposed/sold 10,398 shares
@ $0
Disposed/sold 212,903 options to buy
@ $0
Disposed/sold 23,968 options to buy
@ $121.29, valued at
$2.9M
Disposed/sold 275,436 options to buy
@ $25.03, valued at
$6.9M
Disposed/sold 146,824 options to buy
@ $36.71, valued at
$5.4M
Disposed/sold 51,818 options to buy
@ $11, valued at
$570k
Disposed/sold 99,950 options to buy
@ $22.57, valued at
$2.3M
Disposed/sold 124,600 options to buy
@ $24.75, valued at
$3.1M
Disposed/sold 57,250 options to buy
@ $55.73, valued at
$3.2M
Disposed/sold 28,625 options to buy
@ $55.73, valued at
$1.6M
|
|
| 09/26/2023 |
4
| Edwards Martin (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 6,116 shares
@ $0
Disposed/sold 10,000 options to buy
@ $149.29, valued at
$1.5M
Disposed/sold 6,300 options to buy
@ $149.29, valued at
$940.5k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 99 options to buy
@ $27.32, valued at
$2.7k
Disposed/sold 520 options to buy
@ $34.76, valued at
$18.1k
Disposed/sold 5,620 options to buy
@ $34.76, valued at
$195.4k
Disposed/sold 169 options to buy
@ $93.61, valued at
$15.8k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
|
|
| 09/26/2023 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 6,017 shares
@ $0
Disposed/sold 6,300 options to buy
@ $130.92, valued at
$824.8k
Disposed/sold 5,000 options to buy
@ $146.01, valued at
$730.1k
Disposed/sold 99 options to buy
@ $27.32, valued at
$2.7k
Disposed/sold 416 options to buy
@ $34.76, valued at
$14.5k
Disposed/sold 5,620 options to buy
@ $34.76, valued at
$195.4k
Disposed/sold 135 options to buy
@ $93.61, valued at
$12.6k
Disposed/sold 2,137 options to buy
@ $93.61, valued at
$200k
Disposed/sold 4,500 options to buy
@ $26.46, valued at
$119.1k
Disposed/sold 2,000 options to buy
@ $25.52, valued at
$51k
Disposed/sold 8,000 options to buy
@ $39.48, valued at
$315.8k
|
|
| 09/26/2023 |
4
| Anand Bhaskar (SVP, Chief Accounting Officer) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 24,089 shares
@ $0
Disposed/sold 15,000 options to buy
@ $137.47, valued at
$2.1M
Disposed/sold 23,438 options to buy
@ $27.32, valued at
$640.3k
Disposed/sold 6,000 options to buy
@ $28.78, valued at
$172.7k
Disposed/sold 33,500 options to buy
@ $36.71, valued at
$1.2M
|
|
| 09/26/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/26/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/24/2023 |
4
| ROSE WILLIAM (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Gifted 500,000 shares
@ $0 |
|
| 08/24/2023 |
SC 13D/A
| ROSE WILLIAM reports a 9.1% stake in § 240. REATA PHARMACEUTICALS, INC. |
|
|
|